# INEC Study: Immuno-modulating Enteral Nutrition in Cancer

> **NCT00333099** · PHASE4 · COMPLETED · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 250 (actual)

## Conditions studied

- Malnutrition
- Esophageal Cancer
- Head and Neck Cancer

## Interventions

- **DIETARY_SUPPLEMENT:** Impact (R) Enteral Nutrition
- **OTHER:** impact

## Key facts

- **NCT ID:** NCT00333099
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2010-09
- **Final completion:** 2011-09
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2012-09-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00333099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00333099, "INEC Study: Immuno-modulating Enteral Nutrition in Cancer". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT00333099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*